Same industry

LNTH against four same-industry peers, a year at 100

50100200Jan ’26AprJulOct ’26IDXX−14.5%NEOG×2.2CLDX+21.7%NTLA−48.0%LNTH+87.1%

LNTH +87.1%. Neogen ×2.2, Celldex Therapeutics +21.7%, Idexx Laboratories −14.5%, Intellia Therapeutics −48.0%. Weekly closes, Oct 10, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in LNTH’s SEC industry (In Vitro & In Vivo Diagnostic Substances) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

LNTH: stories, the record and filings →